跳至主要内容
临床试验/NCT01577433
NCT01577433已完成不适用

Driveline Silicone Skin Interface (SSI) Registry

Abbott Medical Devices15 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2012年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
400
试验地点
15
主要终点
Freedom from DL infection events at 12 months after LVAD implantation

研究概览

简要总结

The purpose of this observational registry is to determine the freedom from driveline (DL) infection events in subjects implanted with a HeartMate II LVAD in whom only the silicone portion of the DL is externalized resulting in a silicone skin interface (SSI)

研究设计

研究类型
Observational
观察模型
Other
时间视角
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject has signed the INTERMACS informed consent form
  • Subject has signed the SSI registry informed consent form
  • Subject age ≥ 18 years
  • Subject implanted with a HeartMate II LVAD
  • Subject in whom the full length of the velour portion of the percutaneous lead is fully kept under the skin resulting in a silicone skin interface at the skin exit site
  • In the prospective study cohort, Subject is planned to be supported with the HeartMate II LVAD for at least 12 months
  • In the retrospective study cohort, at the time of enrollment, Subject has been supported with a HeartMate II for at least 10 months

排除标准

  • In the retrospective study cohort, Subject is ongoing with long-term right heart mechanical circulatory support (RVAD)
  • In the retrospective study cohort, Subject had a post-implant sternal re-entry (for bleeding, etc.) or delayed sternal closure
  • In the retrospective study cohort, Subject is participating in any other clinical investigation related to driveline (DL) exit site that could confound the study results
  • In the prospective study cohort, Subject is participating in any other clinical investigation related to driveline (DL) exit site that could confound the study results

结局指标

主要结局

Freedom from DL infection events at 12 months after LVAD implantation

时间窗: 12 Months

次要结局

  • Percentage of subjects with infection events(Month 1, 3, 6, and every six months up to 60 months post-enrollment)
  • DL infection events per patient year(Month 1, 3, 6, and every 6 months up to 60 months post-enrollment)
  • DL tunneling methods or other factors that might reduce risks of DL related infection events(Month 1, 3, 6, and every 6 months up to 60 months post-enrollment)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (15)

Loading locations...

相似试验